CoR |
Nuclear Receptor Co-Repressor |
COVID-19 |
CoronaVirus Disease 2019 |
DAD |
Deacetylase-Activating Domain |
EMT |
Epithelial-to-Mesenchymal Transition |
FDA |
Food and Drug Administration |
FK228 |
Romidepsin |
FPKM |
Fragments Per Kilobase of transcript length per Million of mapped reads |
GTEx |
Genotype-Tissue Expression project |
HAT |
Histone Acetyltransferase |
HCC |
Hepatocellular Carcinoma |
HDAC |
Histone Deacetylase |
HDACi |
Histone Deacetylase inhibitor |
IFN |
Interferon |
LBH589 |
Panobinostat |
LSD1 |
Lysine Demethylase 1 |
MEF2 |
Myocyte Enhancer Factor 2 |
NES |
Nuclear Exporting Signal |
MGCD0103 |
Mocetinostat |
MiDac |
Mitotic Deacetylase Complex |
MS-275 |
Entinostat |
NBL |
Neuroblastoma |
NLS |
Nuclear Localization Sequence |
NR |
Nuclear Receptor |
NuRD |
Nucleosome Remodeling Deacetylase |
PTM |
Post-Translational Modification |
PXD101 |
Belinostat |
RD |
Repression Domain |
REST |
RE1 Silencing Transcription Factor |
SAHA |
Vorinostat |
SARS-CoV-2 |
Severe Acute Respiratory Syndrome CoronaVirus 2 |
SIRT |
Sirtuins |
SMN |
Survival of MotoNeurons |
TCGA |
The Cancer Genome Atlas |
TF |
Transcription Factor |
TNBS |
Triple Negative Breast Cancer |
TSA |
Thrichostatin A |
TSS |
Transcription Start Site |
VPA |
Valproic Acid |